Matthias Hentze receives Centenary Award
EMBL AnnouncementsLab Matters EMBL Heidelberg’s Matthias Hentze receives the Biochemical Society’s Centenary Award for his discoveries in RNA biology.
2022
embl-announcementslab-matters
Read the latest Issue
Blood-clotting protein linked to cancer and septicaemia
In our not-so-distant evolutionary past, stress often meant imminent danger, and the risk of blood loss, so part of our body’s stress response is to stock-pile blood-clotting factors. Scientists in the Molecular Medicine Partnership Unit (MMPU), a collaboration between the European Molecular…
2011
science
Scientists open doors to diagnosis of emphysema
Chronic inflammatory lung diseases like chronic bronchitis and emphysema are a major global health problem, and the fourth leading cause of death and disability in developed countries, with smoking accounting for 90% of the risk for developing them. Work by scientists at the European Molecular…
2009
science
Scientists identify cholesterol-regulating genes
Scientists at the European Molecular Biology Laboratory (EMBL) and the University of Heidelberg, Germany, have come a step closer to understanding how cholesterol levels are regulated. In a study published today in the journal Cell Metabolism, the researchers identified 20 genes that are involved…
2009
science
Recycler protein helps prevent disease
Recycling is important not only on a global scale, but also at the cellular level, since key molecules tend to be available in limited numbers. This means a cell needs to have efficient recycling mechanisms. Researchers at the European Molecular Biology Laboratory (EMBL) and Heidelberg University,…
2009
science
Defusing dangerous mutations
Mutations in genes are the basis of evolution, so we owe our existence to them. Most mutations are harmful, however, because they cause cells to build defective proteins. So cells have evolved quality control mechanisms that recognize and counteract genetic mistakes. Now scientists of the Molecular…
2005
science
Molecular Medicine Partnership Unit initiates second phase
Lab Matters The first rate research from the Molecular Medicine Partnership Unit (MMPU) is now set to continue for the long-term. The European Molecular Biology Laboratory (EMBL) and the Medical Faculty of University of Heidelberg, who formed the joint venture in 2002, have announced their plans to initiate a…
2005
lab-matters
No matching posts found
